New meningitis vaccine shows promise in large trial
NCT ID NCT04368429
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 26 times
Summary
This study tested a single dose of a new meningococcal conjugate vaccine in 360 healthy people aged 2 to 55. The goal was to see if the new vaccine works as well as an existing vaccine at protecting against four types of meningococcal bacteria. Researchers measured immune responses and checked for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGOCOCCAL IMMUNISATION (HEALTHY VOLUNTEERS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number 3920001
Koganeishi, Japan
-
Investigational Site Number 3920002
Shinjuku-Ku, Japan
-
Investigational Site Number 3920003
Shinjuku-Ku, Japan
-
Investigational Site Number 3920004
Nagoya, Japan
Conditions
Explore the condition pages connected to this study.